Evidence map›Paper›PMID 42010744›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2026

Albumin Restores Endothelial Cell Mitochondrial Morphology in Patients With Decompensated Cirrhosis.

Susan E Fischer, Rudmer J Postma, Roel Bijkerk, Annarein J C Kerbert, Anton Jan van Zonneveld, Minneke J Coenraad

Abstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Albumin Restores Endothelial Cell Mitochondrial Morphology in Patients With Decompensated Cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susan E FischerDepartment of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
Rudmer J PostmaDepartment of Internal Medicine (Nephrology) and the Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Centre, Leiden, the Netherlands.ORCID 0000-0002-6797-1499
Roel BijkerkDepartment of Internal Medicine (Nephrology) and the Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Centre, Leiden, the Netherlands.
Annarein J C KerbertDepartment of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
Anton Jan van ZonneveldDepartment of Internal Medicine (Nephrology) and the Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Centre, Leiden, the Netherlands.
Minneke J CoenraadDepartment of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.ORCID 0000-0002-3434-4421

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsEndothelial cell (EC) activation is a critical driver of disease progression in cirrhosis, contributing to acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Although human albumin administration improves EC function in cirrhotic patients with hypoalbuminemia, its direct effects on ECs remain unclear. This ex vivo study investigates the impact of albumin on EC morphology and mitochondrial function upon exposure to plasma from patients with decompensated cirrhosis (DC).

methodsHuman umbilical vein ECs were exposed to plasma from patients with DC and hypoalbuminemia (albumin < 30 g/L, n = 20), compensated cirrhosis (CC, > 30 g/L, n = 20), or healthy controls (HC, n = 20). Albumin was added to DC and HC plasma to reach physiological (~40 g/L) or supraphysiological levels. Mitochondrial function was assessed by measuring oxygen consumption rate (OCR) and reactive oxygen species (ROS) production. The effects of albumin on EC activation were tested using circulating factors elevated in DC (lipopolysaccharide (LPS), tumour necrosis factor-α (TNFα), bilirubin).

resultsMitochondrial morphology distinguished ECs exposed to DC plasma from those exposed to CC or HC plasma. Albumin supplementation shifted EC morphology towards a healthier phenotype. ECs exposed to DC plasma showed increased mitochondrial respiration without a concomitant increase in ROS production, which was normalised by albumin. Albumin had no significant effects on EC activation induced by circulating factors.

conclusionsPlasma from patients with DC and hypoalbuminemia induces EC morphological changes, particularly in mitochondria. Albumin mitigates these effects, suggesting a direct modulatory role on mitochondrial function and supporting its therapeutic potential in vascular dysfunction in cirrhosis.

Indexed as

Endothelial CellsHuman Umbilical Vein Endothelial CellsHypoalbuminemiaLiver CirrhosisMitochondriaAcute-On-Chronic Liver FailureAgedFemaleHumansMaleMiddle AgedOxygen ConsumptionReactive Oxygen SpeciesReactive Oxygen Speciesdecompensated cirrhosisendothelial cell activationhypoalbuminemiamitochondrial functionmitochondrial morphology

Identifiers

PMID42010744
PMCPMC13096249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.